| Reina Nakamura, DO | |
|
325 E Eisenhower Pkwy, Ann Arbor, MI 48108-3364 | |
| (734) 936-7175 | |
| Not Available |
| Full Name | Reina Nakamura |
|---|---|
| Gender | Female |
| Speciality | Sports Medicine |
| Experience | 14 Years |
| Location | 325 E Eisenhower Pkwy, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093135410 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Michigan Health System | Ann arbor, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regents Of The University Of Michigan | 3779496856 | 2953 |
News Archive
A nonsurgical treatment option for rectal cancer that preserves quality of life is safe for carefully selected patients, according to a new study comparing it with the standard operation.
The Ontario Association of Medical Laboratories is pleased to announce its 2010 Small Grants Program to support non-proprietary research projects to improve the efficiency or effectiveness of the delivery of laboratory services. Previously funded projects have included research into new testing methodologies, information systems and improvements to operational systems.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced positive interim biomarker data from the PEARL-SC phase 2b clinical study in patients with systemic lupus erythematosus.
Almost everything that happens inside a cell, including autophagy, is tightly regulated on a biochemical level. Like that, the cell makes sure that processes only take place when they are needed and that they are shut off when the need has expired. "Inside the cell, there exists a network of molecules. Between them, information is constantly being exchanged," says Schmitz, head of the research group "Systems-oriented Immunology and Inflammation Research" at HZI, who also holds a chair at the Otto von Guericke University in Magdeburg.
Pfizer Inc. and Eli Lilly and Company today announced that a 16-week Phase 3 study in patients with osteoarthritis pain evaluating subcutaneous administration of tanezumab, an investigational humanized monoclonal antibody, met all three co-primary endpoints.
› Verified 9 days ago
| Entity Name | Regents Of The University Of Michigan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205868353 PECOS PAC ID: 3779496856 Enrollment ID: O20031106000325 |
News Archive
A nonsurgical treatment option for rectal cancer that preserves quality of life is safe for carefully selected patients, according to a new study comparing it with the standard operation.
The Ontario Association of Medical Laboratories is pleased to announce its 2010 Small Grants Program to support non-proprietary research projects to improve the efficiency or effectiveness of the delivery of laboratory services. Previously funded projects have included research into new testing methodologies, information systems and improvements to operational systems.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced positive interim biomarker data from the PEARL-SC phase 2b clinical study in patients with systemic lupus erythematosus.
Almost everything that happens inside a cell, including autophagy, is tightly regulated on a biochemical level. Like that, the cell makes sure that processes only take place when they are needed and that they are shut off when the need has expired. "Inside the cell, there exists a network of molecules. Between them, information is constantly being exchanged," says Schmitz, head of the research group "Systems-oriented Immunology and Inflammation Research" at HZI, who also holds a chair at the Otto von Guericke University in Magdeburg.
Pfizer Inc. and Eli Lilly and Company today announced that a 16-week Phase 3 study in patients with osteoarthritis pain evaluating subcutaneous administration of tanezumab, an investigational humanized monoclonal antibody, met all three co-primary endpoints.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Reina Nakamura, DO 3621 S State St, Ann Arbor, MI 48108-1633 Ph: (734) 647-5299 | Reina Nakamura, DO 325 E Eisenhower Pkwy, Ann Arbor, MI 48108-3364 Ph: (734) 936-7175 |
News Archive
A nonsurgical treatment option for rectal cancer that preserves quality of life is safe for carefully selected patients, according to a new study comparing it with the standard operation.
The Ontario Association of Medical Laboratories is pleased to announce its 2010 Small Grants Program to support non-proprietary research projects to improve the efficiency or effectiveness of the delivery of laboratory services. Previously funded projects have included research into new testing methodologies, information systems and improvements to operational systems.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced positive interim biomarker data from the PEARL-SC phase 2b clinical study in patients with systemic lupus erythematosus.
Almost everything that happens inside a cell, including autophagy, is tightly regulated on a biochemical level. Like that, the cell makes sure that processes only take place when they are needed and that they are shut off when the need has expired. "Inside the cell, there exists a network of molecules. Between them, information is constantly being exchanged," says Schmitz, head of the research group "Systems-oriented Immunology and Inflammation Research" at HZI, who also holds a chair at the Otto von Guericke University in Magdeburg.
Pfizer Inc. and Eli Lilly and Company today announced that a 16-week Phase 3 study in patients with osteoarthritis pain evaluating subcutaneous administration of tanezumab, an investigational humanized monoclonal antibody, met all three co-primary endpoints.
› Verified 9 days ago
Michael Chia-shao Hsu, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 325 East Eisenhower Pkwy, Suite 100, Ann Arbor, MI 48108 Phone: 734-936-7175 | |
Brian M Kelly, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2850 S Industrial Hwy Ste 400, Ann Arbor, MI 48104 Phone: 734-973-2400 | |
Edward A Hurvitz, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2205 Commonwealth Blvd, Ann Arbor, MI 48105 Phone: 734-936-7175 | |
Lisa A Diponio, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 325 East Eisenhower Pkwy, Suite 100, Ann Arbor, MI 48108 Phone: 734-936-7175 | |
Alecia Kupser Daunter, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2205 Commonwealth, Ann Arbor, MI 48105 Phone: 734-936-7175 | |
Ky Viet Dong Quach, DO Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 325 E Eisenhower Pkwy, Ann Arbor, MI 48108 Phone: 734-936-7175 |